Abstract: The invention relates to the field of transducers, in particular linear vibration generators. It concerns a vibration generator, devices comprising such a vibration generator and a related treatment method. A vibration generator comprising a mass, a coil, a permanent magnet and a housing, wherein the mass can be set in an oscillatory motion with respect to the housing by applying a current to the coil, and the vibration generator further comprising an axle, wherein the oscillatory motion is along the axle, and in that the mass comprises the permanent magnet and the coil is fixed to the housing.

Abstract: The invention relates to devices and methods in the field of mechanical vibrational energy therapy, in particular oscillation stimulation of a subject. A device comprises a housing and the housing comprises a contact surface for being put in contact with the subject; a sensor element configured to detect a contact between the contact surface and the subject and optionally to transform a contact pressure between the contact surface of the device and the subject to which the mechanical vibrational energy is to be applied into a pressure dependent output signal; and a transducer configured to convert an electric input signal into an axial oscillatory motion of a mass, wherein the transducer comprises a coil and a permanent magnet, wherein the mass can be moved relative to the housing, wherein the relative movement of the mass is configured to cause at least the contact surface to vibrate, and wherein the mass comprises the permanent magnet.

Abstract: The present invention relates to a pharmaceutical formulation which provides for extended release of an active pharmaceutical ingredient selected from N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers and the acid addition salts thereof.

Abstract: The present invention relates to a pharmaceutical formulation which provides for extended release of an active pharmaceutical ingredient selected from N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers and the acid addition salts thereof.

Abstract: The present invention relates to a pharmaceutical formulation which provides for extended release of an active pharmaceutical ingredient selected from N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers and the acid addition salts thereof.

Abstract: The present invention relates to a pharmaceutical formulation which provides for extended release of an active pharmaceutical ingredient selected from N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers and the acid addition salts thereof.